A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor

This publication has 35 references indexed in Scilit:

• Plasma and Recombinant Thrombin-activable Fibrinolysis Inhibitor (TAFI) and Activated TAFI Compared with Respect to Glycosylation, Thrombin/Thrombomodulin-dependent Activation, Thermal Stability, and Enzymatic Properties
  Published by Elsevier ,1998
• Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor
  Journal of Biological Chemistry, 1998
• Production and Characterization of Recombinant Human Plasminogen(S741C-Fluorescein)
  Journal of Biological Chemistry, 1997
• A Steady-state Template Model That Describes the Kinetics of Fibrin-stimulated [Glu1]- and [Lys78]Plasminogen Activation by Native tissue-type Plasminogen Activator and Variants That Lack Either the Finger or Kringle-2 Domain
  Published by Elsevier ,1997
• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex
  Published by Elsevier ,1996
• Activation and Characterization of Procarboxypeptidase B from Human Plasma
  Biochemistry, 1995
• An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits
  Biochemical and Biophysical Research Communications, 1989
• α2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin
  Biochemical and Biophysical Research Communications, 1988
• Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition
  European Journal of Biochemistry, 1985
• Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide
  Biochemistry, 1979